About Enanti Labs
Enanti Labs is a company based in Hyderabad (India) founded in 2007. It operates as a B2B. The company has 178 employees. Enanti Labs offers products and services including Active Pharmaceutical Ingredients, Intermediates, and Bulk Drugs. Enanti Labs operates in a competitive market with competitors including Viyash, Inventys, Blue Jet Healthcare, Ami organics and Aparna Pharmaceuticals, among others.
- Headquarter Hyderabad, India
- Employees 178
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website enantilabs.com
- Social LinkedIn Facebook YouTube
- Legal Name Enanti Labs Private Limited
- Date of Incorporation 05 Jul, 2006
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹62.07 Cr
FY 2025 · -14% YoY
- Net Profit₹0.75 Cr
FY 2025 · 1% margin
- EBITDA₹4.72 Cr
FY 2025 · 8% margin
- Employee Count178
Associated legal entities of Enanti Labs
Enanti Labs operates through Enanti Labs Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Enanti Labs Private Limited CIN U24119TG2006PTC050537 | Active | 05 Jul 2006 | Hyderabad, Telangana | ₹62.1 Cr | 178 | 3 | View details |
Products & Services of Enanti Labs
Enanti Labs offers a comprehensive portfolio of products and services, including Active Pharmaceutical Ingredients, Intermediates, and Bulk Drugs.
Production of APIs for drug formulation and quality assurance
Chemical compounds used in synthesizing pharmaceutical APIs
Manufacture of raw materials for generic drug production
Apps and channels of Enanti Labs
its YouTube channel ENANTI LABS PVT LTD has 3 subscribers.
Board of directors of Enanti Labs Private Limited (Enanti Labs)
Enanti Labs Private Limited is the primary company behind Enanti Labs. The board of Enanti Labs Private Limited currently have 3 directors; the longest-serving is Chandra Sekhara Reddi, appointed in 2006. 4 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Chandra Sekhara Reddi DIN 00405725 | Director | 05 Jul 2006 | 20 yrs 3 mo | Enanti Labs Private Limited |
| Bheemireddy Sridhar Reddy DIN 01642391 | Director | 24 Aug 2006 | 20 yrs 1 mo | Enanti Labs Private Limited |
| Mandapati Satyanarayana Reddy DIN 01642348 | Managing Director | 24 Aug 2006 | 20 yrs 1 mo | Enanti Labs Private Limited |
Financials of Enanti Labs
Figures of Enanti Labs Private Limited, the primary company behind Enanti Labs, for FY 2025. Revenue was ₹62.07 Cr (-14% year on year). Net profit was ₹0.75 Cr (1% margin). EBITDA was ₹4.72 Cr (8% margin). Revenue has grown at a compounded annual rate of -12% over three years and +6% over five years.
- ₹62.07 CrRevenue · FY 2025 · -14% YoY
- ₹0.75 CrNet profit · 1% margin
- ₹4.72 CrEBITDA · 8% margin
- ₹5.55 CrPaid-up capital
- 178Employees (provident fund records)
- -12%Revenue CAGR, 3 years
- +6%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Enanti Labs Private Limited are on its company page.
Detailed financial statements for Enanti Labs
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Enanti Labs
Enanti Labs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Viyash, Inventys, Blue Jet Healthcare, Ami organics and Aparna Pharmaceuticals, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| viyash.com | 2019 | Hyderabad, India | $120.0M | 277 | APIs and intermediates are manufactured by Viyash as a CDMO. | |
| inventys.in | 2005 | Mumbai, India | $64.3M | 219 | Actives, advanced intermediates, and specialty chemicals are custom manufactured. | |
| bluejethealthcare.com | 1969 | Mumbai, India | – | 476 | CDMO focused on manufacturing, supplier, and development of intermediates & APIs | |
| amiorganics.com | 2007 | Surat, India | – | 4 | Advanced API intermediates are manufactured for pharmaceutical use. | |
| aparnapharma.com | 2008 | Hyderabad, India | $674,328 | 328 | API intermediates are manufactured by Aparna Pharmaceuticals as a CDMO. | |
| dudechem.com | 2019 | Berlin, Germany | $7.0M | – | CDMO focused on manufacturing of APIs and intermediates | |
| hindyslab.com | 2007 | Hyderabad, India | – | 285 | Manufactures and exports pharmaceutical intermediates for global markets. | |
| hsbiopharm.com | 2004 | Hangzhou, China | – | – | APIs, intermediates, and finished dosage forms are manufactured. |
Detailed competitors of Enanti Labs
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to Enanti Labs
10 companies that operate in the same segment as Enanti Labs (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Enanti Labs
Enanti Labs was founded in 2007.
Enanti Labs is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Enanti Labs has 178 employees.
The primary company behind Enanti Labs, Enanti Labs Private Limited, reported revenue of ₹62.07 Cr for FY 2025, down 14% year on year.
Enanti Labs is an Indian pharmaceutical company established in 2007, focusing on manufacturing bulk drugs, intermediates, and Active Pharmaceutical Ingredients (APIs) with GMP compliance. Operating from Hyderabad as the corporate office and Visakhapatnam for production, they emphasize quality, innovation, and environmental safety. The company aims to provide affordable products through advanced RD and manufacturing facilities, serving the global pharmaceutical industry.
Enanti Labs's top competitors include Inventys, Viyash and Blue Jet Healthcare.
Enanti Labs offers Active Pharmaceutical Ingredients, Intermediates, and Bulk Drugs.
Enanti Labs operates through Enanti Labs Private Limited.
The legal entities of Enanti Labs currently have 3 directors, including Chandra Sekhara Reddi, Bheemireddy Sridhar Reddy, Mandapati Satyanarayana Reddy.